EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells

被引:45
|
作者
Wang, Yang [1 ,2 ,3 ,4 ]
Hu, Jingzhou [1 ,2 ,3 ,4 ]
Wang, Yan'an [1 ,2 ,3 ,4 ]
Ye, Weimin [1 ,2 ,3 ,4 ]
Zhang, Xiangkai [1 ,2 ,3 ,4 ]
Ju, Houyu [1 ,2 ,3 ,4 ]
Xu, Dongliang [5 ]
Liu, Liu [1 ,2 ,3 ,4 ]
Ye, Dongxia [1 ,2 ,3 ,4 ]
Zhang, Ling [1 ,2 ,3 ,4 ]
Zhu, Dongwang [1 ,2 ,3 ,4 ]
Deng, Jiong [5 ]
Zhang, Zhiyuan [1 ,2 ,3 ,4 ]
Liu, Shuli [1 ,2 ,3 ,4 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral & Maxillofacial Head & Neck Oncol, Sch Med, Shanghai, Peoples R China
[2] Shanghai Key Lab Stomatol, Shanghai, Peoples R China
[3] Shanghai Res Inst Stomatol, Shanghai, Peoples R China
[4] Natl Clin Res Ctr Stomatol, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Sch Med, Chinese Minister Educ, Shanghai, Peoples R China
关键词
SACC; EMT; PD-L; Snail; c-Myc; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; CANCER PROGRESSION; METASTASIS; EXPRESSION; HEAD; NECK; INFLAMMATION; INVASION; TWIST;
D O I
10.1080/15384101.2018.1489177
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epithelial-to-mesenchymal transition (EMT) confers cancer cells the ability of invasion and metastasis. However, how does EMT contribute to evasion of immune surveillance is unclear, especially in salivary adenoid cystic carcinoma (SACC). In this study, we investigated the molecular link between EGF-induced EMT and the immune checkpoint ligand programmed death-ligand 1 (PD-L1) by immunoprecipitation (IP) and Westernblot analysis. Cell migration and invasion activity was assayed by transwell assay. Immunohistochemical (IHC) staining analysis was performed for measurement of EMT markers and PD-L1 expression levels in tumor tissues. We found that EGF-induced EGFR activation stabilized Snail expression and induced EMT in SACC. Interestingly, EGFR activation induced simultaneously both EMT and PD-L1 in SACC. Importantly, knockdown of Snail greatly suppressed EGF-induced EMT, but not EGF-induced PD-L1 expression; whereas knockdown of c-Myc strongly repressed PD-L1 expression, but not snail expression and EMT. The molecular link is strongly supported by robust correlations between the EMT markers and PD-L1 expression in human cancer samples.These results suggest that EGFR activated EMT and PD-L1 via two distinct mechanisms. EGFR activation induced EMT and PD-L1 expression in SACC. Snail is required for EGF-induced EMT, but not PD-L1 expression; whereas c-Myc is required for EGFR-mediated PD-L1 upregulation but not EMT. Thus, targeting activated EGFR may inhibit both EMT and PD-L1, which may potentiate the therapeutic effect of PD-L1-based immunotherapy, especially in the malignant subgroups of SACC patients with activated EGFR.
引用
收藏
页码:1457 / 1470
页数:14
相关论文
共 21 条
  • [1] ASSESSMENT OF TUMOUR INFILTRATING LYMPHOCYTES AND PD-L1 EXPRESSION IN ADENOID CYSTIC CARCINOMA OF THE SALIVARY GLAND
    Chen, Wenqian
    Fung, Andrea S.
    McIntyre, John B.
    Simpson, Roderick
    Afzal, Arfan R.
    Hao, Desiree
    Lau, Harold
    CLINICAL AND INVESTIGATIVE MEDICINE, 2021, 44 (01): : E38 - E41
  • [2] Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
    Gowrishankar, Kavitha
    Gunatilake, Dilini
    Gallagher, Stuart J.
    Tiffen, Jessamy
    Rizos, Helen
    Hersey, Peter
    PLOS ONE, 2015, 10 (04):
  • [3] MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells
    Zou, Jiahuan
    Zhuang, Mengwei
    Yu, Xiaopeng
    Li, Na
    Mao, Rudi
    Wang, Zhida
    Wang, Jianing
    Wang, Xiaoyan
    Zhou, Huaiyu
    Zhang, Lining
    Shi, Yongyu
    MOLECULAR IMMUNOLOGY, 2018, 101 : 203 - 209
  • [4] Sex-dependent PD-L1/sPD-L1 trafficking in human endothelial cells in response to inflammatory cytokines and VEGF
    Baggio, Chiara
    Ramaschi, Giovanni Eugenio
    Oliviero, Francesca
    Ramonda, Roberta
    Sfriso, Paolo
    Trevisi, Lucia
    Cignarella, Andrea
    Bolego, Chiara
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [5] Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer
    Tomasich, Erwin
    Topakian, Thais
    Heller, Gerwin
    Udovica, Simon
    Krainer, Michael
    Marhold, Maximilian
    TRANSLATIONAL RESEARCH, 2021, 230 : 21 - 33
  • [6] FOXO3-dependent suppression of PD-L1 promotes anticancer immune responses via activation of natural killer cells
    Chung, Young Min
    Bin Tsai, Wen
    Khan, Pragya P.
    Ma, Jessica
    Berek, Jonathan S.
    Larrick, James W.
    Hu, Mickey C-T
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (03): : 1241 - 1263
  • [7] Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
    Hwang, Hyun Jung
    Kang, Donghee
    Shin, Jisoo
    Jung, Jonghun
    Ko, Soyeon
    Jung, Kyung Hee
    Hong, Soon-Sun
    Park, Ji Eun
    Oh, Myung Jin
    An, Hyun Joo
    Yang, Wen-Hao
    Ko, Young-Gyu
    Cha, Jong-Ho
    Lee, Jae-Seon
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [8] DISRUPTION OF FGL2 INDUCED TFEB-DEPENDENT LYSOSOMAL DEGRADATION OF PD-L1 AND ENHANCED THE EFFICACY OF ANTI-PD-1 THERAPY IN HEPATOCELLULAR CARCINOMA
    Han, Meiwen
    Guan, Qianting
    Yan, Fangfei
    Guo, Qinghao
    Wang, Ming
    Xi, Dong
    Ning, Qin
    HEPATOLOGY, 2024, 80
  • [9] Human Corneal Endothelial Cells Expressing Programmed Death-Ligand 1 (PD-L1) Suppress PD-1+ T Helper 1 Cells by a Contact-Dependent Mechanism
    Sugita, Sunao
    Usui, Yoshihiko
    Horie, Shintaro
    Futagami, Yuri
    Yamada, Yukiko
    Ma, Juan
    Kezuka, Takeshi
    Hamada, Hirofumi
    Usui, Tomohiko
    Mochizuki, Manabu
    Yamagami, Satoru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (01) : 263 - 272
  • [10] Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfb-Dependent Mechanisms
    Yu, Haocheng
    Sfakianos, John P.
    Wang, Li
    Hu, Yang
    Daza, Jorge
    Galsky, Matthew D.
    Sandhu, Harkirat S.
    Elemento, Olivier
    Faltas, Bishoy M.
    Farkas, Adam M.
    Bhardwaj, Nina
    Zhu, Jun
    Mulholland, David J.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (11) : 1729 - 1741